蔘考文獻
- 2019-11-06 17:20:45
- ADC秘書處
- 2912
- 最後編輯：admin 於 2019-11-06 18:33:07
[2] Alzheimer′s Association. 2015 Alzheimer′s disease facts and figures[J]. Alzheimers Dement, 2015,11(3): 332-384.
[3] Ingles JL, Wentzel C, Fisk JD, et al. Neuropsychological predictors of incident dementia in patients with vascular cognitive impairment, without dementia[J]. Stroke, 2002,33(8): 1999-2002.
[4] Leys D, Hénon H, Mackowiak-Cordoliani MA, et al. Poststroke dementia[J]. Lancet Neurol, 2005, 4(11): 752-759. DOI: 10.1016/S1474-4422(05)70221-0.
[5] Chui H. Vascular dementia, a new beginning: shifting focus from clinical phenotype to ischemic brain injury[J]. Neurol Clin, 2000,18(4):951-978.
[6] Román GC, Salloway S, Black SE, et al. Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia: differential effects by hippocampal size[J]. Stroke, 2010, 41(6):1213-1221. DOI: 10.1161/STROKEAHA.109.570077.
[7] Wilcock G, Möbius HJ, Stöffler A. A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500) [J]. Int Clin Psychopharmacol, 2002,17(6):297-305.
[8] Orgogozo JM, Rigaud AS, Stöffler A, et al. Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300)
[J]. Stroke, 2002,33(7):1834-1839.
[9] 張振馨, 陳霞, 劉協和, 等. 北京、西安、上海、成都四地區 癡獃患者衛生保健現狀調查[J].中國醫學科學院學報, 2004,26(2):116-121.
[10] Chen R, Hu Z, Chen RL, et al. Determinants for undetected dementia and late-life depression[J]. Br J Psychiatry, 2013,203 (3):203-208. DOI: 10.1192/bjp.bp.112.119354.
[11] 田金洲, 解恆革, 秦斌, 等. 中國簡短認知測試在癡獃診斷中的應用指南[J]. 中華醫學雜誌,2016,96(37):2945-2959. DOI: 10.3760/cma.j.issn.0376-2491.2016.37.001.
[12] Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/ American Stroke Association[J]. Stroke, 2011,42(9):2672-2713. DOI: 10.1161/STR.0b013e3182299496.
[13] American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5) [M / OL]. [2018-09-01]. http://www.dsm5.org.
[14] Sachdev P, Kalaria R, O′Brien J, et al. Diagnostic criteria for vascular cognitive disorders: a VASCOG statement[J]. Alzheimer Dis Assoc Disord, 2014, 28(3): 206-218. DOI:10.1097/WAD.0000000000000034.
[15] American Psychiatric Association. Diagnostic and statistical manual of mental disorders 4th edition. text revision(DSM-IV-TR) [M]. Arlington: American Psychiatric Association, 2000.
[16] Edwards JD, Jacova C, Sepehry AA, et al. A quantitative systematic review of domain-specific cognitive impairment in lacunar stroke[J]. Neurology, 2013, 80(3): 315-322. DOI: 10.1212/WNL.0b013e31827deb85.
[17] Román GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop[J]. Neurology, 1993,43(2):250-260.
[18] Vasquez BP, Zakzanis KK. The neuropsychological profile of vascular cognitive impairment not demented: a meta-analysis[J]. J Neuropsychol, 2015,9(1):109-136. DOI: 10.1111/jnp.12039.
[19] Benson DF, Cummings JL. Angular gyrus syndrome simulating Alzheimer′s disease[J]. Arch Neurol, 1982,39(10): 616-620.
[20] Damasio AR, Damasio H. The anatomic basis of pure alexia [J]. Neurology, 1983,33(12):1573-1583.
[21] Lopez OL, Kuller LH, Becker JT, et al. Classification of vascular dementia in the cardiovascular health study cognition study[J]. Neurology, 2005,64(9):1539-1547. DOI: 10.1212/01. WNL.0000159860.19413.C4.
[22] Ankolekar S, Geeganage C, Anderton P, et al. Clinical trials for preventing post stroke cognitive impairment[J]. J Neurol Sci, 2010,299(1-2):168-174. DOI: 10.1016/j.jns.2010.08.052.
[23] Cumming TB, Marshall RS, Lazar RM. Stroke, cognitive deficits, and rehabilitation: still an incomplete picture[J]. Int J Stroke, 2013,8(1):38-45. DOI: 10.1111/j.1747-4949.2012.00972.x.
[24] Hachinski V, Iadecola C, Petersen RC, et al.National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards [J]. Stroke, 2006, 37(9): 2220-2241. DOI: 10.1161 / 01. STR. 0000237236.88823.47.
[25] Skrobot OA, O′Brien J, Black S, et al. The vascular impairment of cognition classification consensus study[J]. Alzheimers Dement, 2017,13(6):624-633. DOI: 10.1016/j.jalz. 2016.10.007.
[26] Skrobot OA, Black SE, Chen C, et al. Progress toward standardized diagnosis of vascular cognitive impairment: guidelines from the vascular impairment of cognition classification consensus study[J]. Alzheimers Dement, 2018,14 (3):280-292. DOI: 10.1016/j.jalz.2017.09.007.
[27] 田金洲, 解恆革, 秦斌, 等. 中國血管性輕度認知損害診斷指南[J]. 中華內科雜誌,2016,55(3):249-256. DOI: 10.3760/cma.j.issn.0578-1426.2016.03.022.
[28] 時晶, 解恆革, 秦斌, 等.《中國血管性輕度認知損害診斷指南》中的幾箇關鍵問題[J]. 中華醫學雜誌,2016,96(47):3779-3781. DOI: 10.3760/cma.j.issn.0376-2491.2016.47.002.
[29] Pendlebury ST, Mariz J, Bull L, et al. Impact of different operational definitions on mild cognitive impairment rate and MMSE and MoCA performance in transient ischaemic attack and stroke[J]. Cerebrovasc Dis, 2013,36(5-6):355-362. DOI: 10.1159/000355496.
[30] Pendlebury ST, Mariz J, Bull L, et al. MoCA, ACE-R, and MMSE versus the National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards neuropsychological battery after TIA and stroke[J]. Stroke, 2012,43(2):464-469. DOI: 10.1161/STROKEAHA.111.633586.
[31] Godefroy O, Fickl A, Roussel M, et al. Is the Montreal cognitive assessment superior to the mini-mental state examination to detect poststroke cognitive impairment? A study with neuropsychological evaluation[J]. Stroke, 2011,42 (6):1712-1716. DOI: 10.1161/STROKEAHA.110.606277.
[32] Cumming TB, Churilov L, Linden T, et al. Montreal cognitive assessment and mini-mental state examination are both valid cognitive tools in stroke[J]. Acta Neurol Scand, 2013,128(2): 122-129. DOI: 10.1111/ane.12084.
[33] Tsoi KK, Chan JY, Hirai HW, et al. Cognitive tests to detect dementia: a systematic review and meta-analysis[J]. JAMA Intern Med, 2015,175(9):1450-1458. DOI: 10.1001/jamainternmed. 2015.2152.
[34] Lees R, Selvarajah J, Fenton C, et al. Test accuracy of cognitive screening tests for diagnosis of dementia and multidomain cognitive impairment in stroke[J]. Stroke, 2014, 45(10):3008-3018. DOI: 10.1161/STROKEAHA.114.005842.
[35] Qu Y, Zhuo L, Li N, et al. Prevalence of post-stroke cognitive impairment in china: a community-based, cross-sectional study [J]. PLoS One, 2015,10(4):e0122864. DOI: 10.1371/journal. pone.0122864.
[36] Kaya Y, Aki OE, Can UA, et al. Validation of Montreal cognitive assessment and discriminant power of Montreal cognitive assessment subtests in patients with mild cognitive impairment and Alzheimer dementia in Turkish population[J]. J Geriatr Psychiatry Neurol, 2014, 27(2): 103-109. DOI: 10.
1177/0891988714522701.
[37] Yu J, Li J, Huang X. The Beijing version of the Montreal cognitive assessment as a brief screening tool for mild cognitive impairment: a community-based study[J]. BMC Psychiatry, 2012,12: 156. DOI: 10.1186/1471-244X-12-156.
[38] Xu Q, Cao WW, Mi JH, et al. Brief screening for mild cognitive impairment in subcortical ischemic vascular disease: a comparison study of the Montreal cognitive assessment with the mini-mental state examination[J]. Eur Neurol, 2014, 71 (3-4):106-114. DOI: 10.1159/000353988.
[39] Chiti G, Pantoni L. Use of Montreal cognitive assessment in patients with stroke[J]. Stroke, 2014,45(10):3135-3140. DOI: 10.1161/STROKEAHA.114.004590.
[40] Roalf DR, Moberg PJ, Xie SX, et al. Comparative accuracies of two common screening instruments for classification of Alzheimer′s disease, mild cognitive impairment, and healthy aging[J]. Alzheimers Dement, 2013,9(5):529-537. DOI: 10. 1016/j.jalz.2012.10.001.
[41] Chui HC, Victoroff JI, Margolin D, et al. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer′s Disease Diagnostic and Treatment Centers[J]. Neurology, 1992,42(3 Pt 1):473-480.
[42] 田金洲.中國癡獃診療指南(2017年版)[M].北京:人民衛生齣版社,2018: 35-39.
發錶評論
版權聲明
本網所有內容文字、圖片和音視頻資料，版權均屬ADC網站所有，任何媒體、網站或箇人未經本網協議授權不得轉載、鏈接、轉貼或以其他方式複製髮佈/髮錶。
已經本網協議授權的媒體、網站，在下載、轉載或引用使用時必鬚註明"稿件來源：中國老年保健協會阿爾茨海默病協會網"，併標明ADC網址www.adc.org.cn，違者ADC將依法追究責任。
轉載或引用本網中的署名文章，請按規定曏作者支付稿酬。
